Human metapneumovirus infections in hospitalized children G Boivin, G De Serres, S Côté, R Gilca, Y Abed, L Rochette, MG Bergeron, ... Emerging infectious diseases 9 (6), 634, 2003 | 568 | 2003 |
Epidemiology of varicella zoster virus infection in Canada and the United Kingdom M Brisson, WJ Edmunds, B Law, NJ Gay, R Walld, M Brownell, LL Roos, ... Epidemiology & Infection 127 (2), 305-314, 2001 | 508 | 2001 |
Low 2012–13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses DM Skowronski, NZ Janjua, G De Serres, S Sabaiduc, A Eshaghi, ... PloS one 9 (3), e92153, 2014 | 497 | 2014 |
Morbidity of pertussis in adolescents and adults G De Serres, R Shadmani, B Duval, N Boulianne, P Déry, MD Fradet, ... The Journal of infectious diseases 182 (1), 174-179, 2000 | 421 | 2000 |
Association between the 2008–09 seasonal influenza vaccine and pandemic H1N1 illness during spring–summer 2009: four observational studies from Canada DM Skowronski, G De Serres, NS Crowcroft, NZ Janjua, N Boulianne, ... PLoS medicine 7 (4), e1000258, 2010 | 353 | 2010 |
Modelling the impact of immunization on the epidemiology of varicella zoster virus M Brisson, WJ Edmunds, NJ Gay, B Law, G De Serres Epidemiology & Infection 125 (3), 651-669, 2000 | 320 | 2000 |
Repeated annual influenza vaccination and vaccine effectiveness: review of evidence EA Belongia, DM Skowronski, HQ McLean, C Chambers, ME Sundaram, ... Expert review of vaccines 16 (7), 723-736, 2017 | 296 | 2017 |
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness EW Orenstein, G De Serres, MJ Haber, DK Shay, CB Bridges, P Gargiullo, ... International journal of epidemiology 36 (3), 623-631, 2007 | 290 | 2007 |
The changing age and seasonal profile of pertussis in Canada DM Skowronski, G De Serres, D MacDonald, W Wu, C Shaw, J Macnabb, ... Journal of Infectious Diseases 185 (10), 1448-1453, 2002 | 275 | 2002 |
The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials G De Serres, DM Skowronski, XW Wu, CS Ambrose Eurosurveillance 18 (37), 20585, 2013 | 273 | 2013 |
An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility G Boivin, GD Serres, ME Hamelin, S Côté, M Argouin, G Tremblay, ... Clinical Infectious Diseases 44 (9), 1152-1158, 2007 | 255 | 2007 |
Epidemiology of transmissible diseases after elimination G De Serres, NJ Gay, CP Farrington American journal of epidemiology 151 (11), 1039-1048, 2000 | 242 | 2000 |
A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014–2015 season DM Skowronski, C Chambers, S Sabaiduc, G De Serres, AL Winter, ... Clinical Infectious Diseases 63 (1), 21-32, 2016 | 226 | 2016 |
Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005–2006 season of dual A and B vaccine mismatch … DM Skowronski, C Masaro, TL Kwindt, A Mak, M Petric, Y Li, R Sebastian, ... Vaccine 25 (15), 2842-2851, 2007 | 214 | 2007 |
Human bocavirus infections in hospitalized children and adults J Longtin, M Bastien, R Gilca, E Leblanc, G De Serres, MG Bergeron, ... Emerging infectious diseases 14 (2), 217, 2008 | 213 | 2008 |
Rapid decline of influenza vaccine—induced antibody in the elderly: is it real, or is it relevant? DM Skowronski, SA Tweed, SA Tweed, G De Serres The Journal of infectious diseases 197 (4), 490-502, 2008 | 205 | 2008 |
Multiplex real-time PCR assay for detection of influenza and human respiratory syncytial viruses G Boivin, S Côté, P Déry, G De Serres, MG Bergeron Journal of clinical Microbiology 42 (1), 45-51, 2004 | 203 | 2004 |
Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children J Papenburg, MÈ Hamelin, N Ouhoummane, J Carbonneau, M Ouakki, ... The Journal of infectious diseases 206 (2), 178-189, 2012 | 181 | 2012 |
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses A Tauzin, M Nayrac, M Benlarbi, SY Gong, R Gasser, ... Cell host & microbe 29 (7), 1137-1150. e6, 2021 | 171 | 2021 |
Molecular confirmation of hepatitis A virus from well water: epidemiology and public health implications GD Serres, TL Cromeans, B Levesque, N Brassard, C Barthe, M Dionne, ... The Journal of infectious diseases 179 (1), 37-43, 1999 | 171 | 1999 |